231 related articles for article (PubMed ID: 37440106)
21. Tanshinone IIA promotes apoptosis by downregulating BCL2 and upregulating TP53 in triple-negative breast cancer.
Liu J; Zhang C; Liu S; Wang X; Wu X; Hao J
Naunyn Schmiedebergs Arch Pharmacol; 2023 Feb; 396(2):365-374. PubMed ID: 36374307
[TBL] [Abstract][Full Text] [Related]
22. Tanshinone IIA alleviates blast-induced inflammation, oxidative stress and apoptosis in mice partly by inhibiting the PI3K/Akt/FoxO1 signaling pathway.
Liu Y; Tong C; Tang Y; Cong P; Liu Y; Shi X; Shi L; Zhao Y; Jin H; Li J; Hou M
Free Radic Biol Med; 2020 May; 152():52-60. PubMed ID: 32131025
[TBL] [Abstract][Full Text] [Related]
23. A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment.
Bi Z; Wang Y; Zhang W
Biomed Pharmacother; 2021 May; 137():111404. PubMed ID: 33761617
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines.
Wang L; Wu J; Lu J; Ma R; Sun D; Tang J
Mol Med Rep; 2015 Feb; 11(2):931-9. PubMed ID: 25355053
[TBL] [Abstract][Full Text] [Related]
25. Synergistic effects of tanshinone IIA and andrographolide on the apoptosis of cancer cells via crosstalk between p53 and reactive oxygen species pathways.
Li Y; Jiang B; Wang R; Wang J; Li Y; Bao Y
Pharmacol Rep; 2020 Apr; 72(2):400-417. PubMed ID: 32048269
[TBL] [Abstract][Full Text] [Related]
26. Tanshinone IIA inhibited intermittent hypoxia induced neuronal injury through promoting autophagy via AMPK-mTOR signaling pathway.
Si J; Liu B; Qi K; Chen X; Li D; Yang S; Ji E
J Ethnopharmacol; 2023 Oct; 315():116677. PubMed ID: 37268259
[TBL] [Abstract][Full Text] [Related]
27. Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt/mTOR/p70S6K pathway in a murine model of systemic sclerosis.
Jiang Y; Hu F; Li Q; Shen C; Yang J; Li M
Int Immunopharmacol; 2019 Dec; 77():105968. PubMed ID: 31704290
[TBL] [Abstract][Full Text] [Related]
28. An overview of the anti-cancer actions of Tanshinones, derived from
Naz I; Merarchi M; Ramchandani S; Khan MR; Malik MN; Sarwar S; Narula AS; Ahn KS
Explor Target Antitumor Ther; 2020; 1(3):153-170. PubMed ID: 36046197
[TBL] [Abstract][Full Text] [Related]
29. Potentiation of the anticancer effect of doxorubicinin drug-resistant gastric cancer cells by tanshinone IIA.
Xu Z; Chen L; Xiao Z; Zhu Y; Jiang H; Jin Y; Gu C; Wu Y; Wang L; Zhang W; Zuo J; Zhou D; Luan J; Shen J
Phytomedicine; 2018 Dec; 51():58-67. PubMed ID: 30466628
[TBL] [Abstract][Full Text] [Related]
30. Tanshinone IIA inhibits osteosarcoma growth through modulation of AMPK-Nrf2 signaling pathway.
Xie Z; He B; Jiang Z; Zhao L
J Recept Signal Transduct Res; 2020 Dec; 40(6):591-598. PubMed ID: 32496906
[TBL] [Abstract][Full Text] [Related]
31. Tanshinone IIA: A Review of its Anticancer Effects.
Fang ZY; Zhang M; Liu JN; Zhao X; Zhang YQ; Fang L
Front Pharmacol; 2020; 11():611087. PubMed ID: 33597880
[TBL] [Abstract][Full Text] [Related]
32. Study on optimisation of extraction process of tanshinone IIA and its mechanism of induction of gastric cancer SGC7901 cell apoptosis.
Hou J; He J; Jin X; Hu T; Zhang Y
Afr J Tradit Complement Altern Med; 2013; 10(6):456-8. PubMed ID: 24311868
[TBL] [Abstract][Full Text] [Related]
33. Potential therapeutic roles of tanshinone IIA in human bladder cancer cells.
Chiu SC; Huang SY; Chang SF; Chen SP; Chen CC; Lin TH; Liu HH; Tsai TH; Lee SS; Pang CY; Hsieh TF
Int J Mol Sci; 2014 Sep; 15(9):15622-37. PubMed ID: 25192287
[TBL] [Abstract][Full Text] [Related]
34. Tanshinone IIA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitro.
Zhang Y; Wei RX; Zhu XB; Cai L; Jin W; Hu H
Anticancer Drugs; 2012 Feb; 23(2):212-9. PubMed ID: 22126901
[TBL] [Abstract][Full Text] [Related]
35. Tanshinone IIA Inhibits Triple-Negative Breast Cancer Cells MDA-MB-231 via G Protein-Coupled Estrogen Receptor- (GPER-) Dependent Signaling Pathway.
He Y; Yang K; Liu J; Shi D; Zhang Z; Yang J; Chen M; Zhao P
Dis Markers; 2023; 2023():8371623. PubMed ID: 36741908
[TBL] [Abstract][Full Text] [Related]
36. Tanshinone-IIA mediated neuroprotection by modulating neuronal pathways.
Sherawat K; Mehan S
Naunyn Schmiedebergs Arch Pharmacol; 2023 Aug; 396(8):1647-1667. PubMed ID: 37010572
[TBL] [Abstract][Full Text] [Related]
37. Tanshinone I inhibits vascular smooth muscle cell proliferation by targeting insulin-like growth factor-1 receptor/phosphatidylinositol-3-kinase signaling pathway.
Wu YT; Bi YM; Tan ZB; Xie LP; Xu HL; Fan HJ; Chen HM; Li J; Liu B; Zhou YC
Eur J Pharmacol; 2019 Jun; 853():93-102. PubMed ID: 30878387
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxicity of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on HepG2 cells in relation to glutathione perturbation.
Lee WY; Chiu LC; Yeung JH
Food Chem Toxicol; 2008 Jan; 46(1):328-38. PubMed ID: 17892911
[TBL] [Abstract][Full Text] [Related]
39. Tanshinone IIA reduces secretion of pro‑angiogenic factors and inhibits angiogenesis in human colorectal cancer.
Zhou L; Sui H; Wang T; Jia R; Zhang Z; Fu J; Feng Y; Liu N; Ji Q; Wang Y; Zhang B; Li Q; Li Y
Oncol Rep; 2020 Apr; 43(4):1159-1168. PubMed ID: 32323837
[TBL] [Abstract][Full Text] [Related]
40. Salviolone from
Zanrè V; Campagnari R; Cerulli A; Masullo M; Cardile A; Piacente S; Menegazzi M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
